OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on the Diagnosis and Management of Wilson Disease
Eve A. Roberts
Current Gastroenterology Reports (2018) Vol. 20, Iss. 12
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson’s disease
Jianjian Dong, Xun Wang, Chenchen Xu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 79

Wilson’s Disease: An Update on the Diagnostic Workup and Management
Beata Kasztelan‐Szczerbińska, Halina Cichoż‐Lach
Journal of Clinical Medicine (2021) Vol. 10, Iss. 21, pp. 5097-5097
Open Access | Times Cited: 60

Wilson Disease: Update on Pathophysiology and Treatment
Som Dev, Robert L. Kruse, James P. Hamilton, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 42

Copper-Induced Neurodegenerative Disorders and Therapeutic Potential of Curcumin-Loaded Nanoemulsion
Govind Hake, Akshada Mhaske, Rahul Shukla, et al.
Toxics (2025) Vol. 13, Iss. 2, pp. 108-108
Open Access | Times Cited: 1

Wilson disease
Annu Aggarwal, Mohit Bhatt
Current Opinion in Neurology (2020) Vol. 33, Iss. 4, pp. 534-542
Closed Access | Times Cited: 57

Challenges in the diagnosis of Wilson disease
Aurélia Poujois, France Woimant
Annals of Translational Medicine (2019) Vol. 7, Iss. S2, pp. S67-S67
Open Access | Times Cited: 53

Recent advances in Wilson disease
Maryam Moini, Uyen To, Michael L. Schilsky
Translational Gastroenterology and Hepatology (2021) Vol. 6, pp. 21-21
Open Access | Times Cited: 39

Systemic deletion of Atp7b modifies the hepatocytes’ response to copper overload in the mouse models of Wilson disease
Abigael Muchenditsi, C. Conover Talbot, Aline Gottlieb, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 36

Ferulic Acid Activates SIRT1-Mediated Ferroptosis Signaling Pathway to Improve Cognition Dysfunction in Wilson’s Disease
Xie Wang, Nan Shao, Xiaoyan Zhang, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 2681-2696
Open Access | Times Cited: 13

Wilson’s Disease with Acute Hepatic Onset: How to Diagnose and Treat It
Valeria Delle Cave, Fabiola Di Dato, Raffaele Iorio
Children (2024) Vol. 11, Iss. 1, pp. 68-68
Open Access | Times Cited: 5

WilsonGenAI a deep learning approach to classify pathogenic variants in Wilson Disease
Aastha Vatsyayan, Mukesh Kumar, Bhaskar Jyoti Saikia, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303787-e0303787
Open Access | Times Cited: 4

Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system
Vijay Kumar, Anand Singh, Nicholas Wheeler, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 11, pp. 1443-1450
Closed Access | Times Cited: 21

Effects of Dietary Glucose and Fructose on Copper, Iron, and Zinc Metabolism Parameters in Humans
Nathaniel H. O. Harder, Bettina Hieronimus, Kimber L. Stanhope, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2581-2581
Open Access | Times Cited: 23

Copper impairs the intestinal barrier integrity in Wilson disease
Adriana Fontes, Hannah Pierson, Joanna B. Bierła, et al.
Metabolism (2024) Vol. 158, pp. 155973-155973
Open Access | Times Cited: 2

A review and update on the diagnosis and treatment of neuropsychiatric Wilson disease
Sean V Cleymaet, Katsuko Nagayoshi, Edward Gettings, et al.
Expert Review of Neurotherapeutics (2019) Vol. 19, Iss. 11, pp. 1117-1126
Closed Access | Times Cited: 22

Actionable Exomic Secondary Findings in 280 Lebanese Participants
Nadine Jalkh, Cybel Mehawej, Éliane Chouery
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 18

Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the national health insurance database
Thomas Daniel-Robin, Bernard Bénichou, Claire Leboucher, et al.
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 10, pp. 101992-101992
Closed Access | Times Cited: 12

Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects
Fitri Fareez Ramli, Syed Alhafiz Syed Hashim, Betty Raman, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1145-1145
Open Access | Times Cited: 11

Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects
Karl Heinz Weiss, Catherine Thompson, Peter Dogterom, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2021) Vol. 46, Iss. 5, pp. 665-675
Closed Access | Times Cited: 13

Population screening and diagnostic strategies in screening family members of Wilson’s disease patients
Huamei Li, Ran Tao, Lifang Liu, et al.
Annals of Translational Medicine (2019) Vol. 7, Iss. S2, pp. S59-S59
Open Access | Times Cited: 13

Renal Tubular Function, Bone Health and Body Composition in Wilson’s Disease: A Cross-Sectional Study from India
Nitin Kapoor, Kripa Elizabeth Cherian, K.G. Sajith, et al.
Calcified Tissue International (2019) Vol. 105, Iss. 5, pp. 459-465
Closed Access | Times Cited: 13

Page 1 - Next Page

Scroll to top